Market Cap 192.13M
Revenue (ttm) 4.06M
Net Income (ttm) -50.22M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,236.95%
Debt to Equity Ratio 0.00
Volume 240,200
Avg Vol 411,742
Day's Range N/A - N/A
Shares Out 32.29M
Stochastic %K 39%
Beta 1.79
Analysts Sell
Price Target $8.33

Company Profile

Insight Molecular Diagnostics Inc. operates as a precision diagnostics company in the United States and internationally. The company develops and commercializes laboratory developed tests, kitted research use only tests, and kitted clinical tests. It is developing DetermaCNI, a blood-based monitoring tool that detects progression early after one cycle cancer treatment; and DetermaIO, a gene expression test that assesses the tumor microenvironment to predict response to immunotherapies. The compa...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 949 409 7600
Address:
2 International Plaza Dr., Suite 510, Nashville, United States
JohnPDaly
JohnPDaly Jun. 1 at 1:35 PM
$IMDX bought a little more. Neil B and I own 40% of this company now.
0 · Reply
JohnPDaly
JohnPDaly May. 28 at 4:17 PM
$IMDX bought more.
0 · Reply
SuperGreenToday
SuperGreenToday May. 28 at 2:34 AM
$IMDX Share Price: $6.41 Contract Selected: Dec 18, 2026 $5 Calls Buy Zone: $0.47 – $0.58 Target Zone: $0.80 – $0.97 Potential Upside: 61% ROI Time to Expiration: 204 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
jackedmund99
jackedmund99 May. 27 at 8:01 PM
$IMDX there’s no doubt with the way the Stock has been acting the last couple of months. This Stock is under serious consideration and consolidation and accumulation look at the way you perform today somebody wants to stock in a big way.
0 · Reply
JohnPDaly
JohnPDaly May. 20 at 10:08 PM
$IMDX well, school is out. When school goes back in, we should be approved.
0 · Reply
juliano777
juliano777 May. 20 at 9:39 PM
$IMDX very strong 💪🏽 happy to be in
0 · Reply
jackedmund99
jackedmund99 May. 20 at 7:50 PM
$IMDX Stock is gonna go to 20 or $30. Over the next two years as products come out there’s a huge market there and people aren’t even paying attention.
1 · Reply
quiet_investor_
quiet_investor_ May. 19 at 4:43 PM
$IMDX holding since the $4's bought more at lunch today.
0 · Reply
Logic102
Logic102 May. 18 at 2:24 PM
$IMDX An Oasis in a Sea of Red with the sector being beaten down with the FDA turmoil.
0 · Reply
WarrenPsnik
WarrenPsnik May. 14 at 6:54 PM
$IMDX Still holding, but didn’t get to add anymore …
1 · Reply
Latest News on IMDX
Insight Molecular Diagnostics Earnings Call Transcript: Q1 2026

May 13, 2026, 5:00 PM EDT - 21 days ago

Insight Molecular Diagnostics Earnings Call Transcript: Q1 2026


Insight Molecular Diagnostics Earnings release: Q1 2026

May 13, 2026, 5:00 PM EDT - 21 days ago

Insight Molecular Diagnostics Earnings release: Q1 2026


Insight Molecular Diagnostics Shareholder letter: Q1 2026

May 13, 2026, 5:00 PM EDT - 21 days ago

Insight Molecular Diagnostics Shareholder letter: Q1 2026


Insight Molecular Diagnostics Quarterly report: Q1 2026

May 13, 2026, 5:00 PM EDT - 21 days ago

Insight Molecular Diagnostics Quarterly report: Q1 2026


Insight Molecular Diagnostics Slides: Investor presentation

May 13, 2026, 4:00 PM EDT - 21 days ago

Insight Molecular Diagnostics Slides: Investor presentation


iMDx to Release First Quarter 2026 Results on May 13, 2026

May 6, 2026, 4:05 PM EDT - 4 weeks ago

iMDx to Release First Quarter 2026 Results on May 13, 2026


Insight Molecular Diagnostics Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 5 weeks ago

Insight Molecular Diagnostics Proxy statement: Proxy filing


Insight Molecular Diagnostics Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 5 weeks ago

Insight Molecular Diagnostics Proxy statement: Proxy filing


Insight Molecular Diagnostics Earnings Call Transcript: Q4 2025

Mar 26, 2026, 5:00 PM EDT - 2 months ago

Insight Molecular Diagnostics Earnings Call Transcript: Q4 2025


Insight Molecular Diagnostics Shareholder letter: Q4 2025

Mar 26, 2026, 5:00 PM EDT - 2 months ago

Insight Molecular Diagnostics Shareholder letter: Q4 2025


Insight Molecular Diagnostics Annual report: Q4 2025

Mar 26, 2026, 5:00 PM EDT - 2 months ago

Insight Molecular Diagnostics Annual report: Q4 2025


Insight Molecular Diagnostics Earnings release: Q4 2025

Mar 26, 2026, 5:00 PM EDT - 2 months ago

Insight Molecular Diagnostics Earnings release: Q4 2025


Insight Molecular Diagnostics Slides: Investor presentation

Mar 26, 2026, 4:00 PM EDT - 2 months ago

Insight Molecular Diagnostics Slides: Investor presentation


iMDx Announces $26.0 Million Registered Direct Offering

Feb 11, 2026, 8:00 AM EST - 4 months ago

iMDx Announces $26.0 Million Registered Direct Offering


iMDx prepares for U.S. commercial launch of GraftAssureDx

2026-01-05T12:11:39.000Z - 5 months ago

iMDx prepares for U.S. commercial launch of GraftAssureDx


Insight Molecular Diagnostics Earnings Call Transcript: Q3 2025

Nov 10, 2025, 5:00 PM EST - 7 months ago

Insight Molecular Diagnostics Earnings Call Transcript: Q3 2025


Insight Molecular Diagnostics Shareholder letter: Q3 2025

Nov 10, 2025, 5:00 PM EST - 7 months ago

Insight Molecular Diagnostics Shareholder letter: Q3 2025


Insight Molecular Diagnostics Quarterly report: Q3 2025

Nov 10, 2025, 5:00 PM EST - 7 months ago

Insight Molecular Diagnostics Quarterly report: Q3 2025


Insight Molecular Diagnostics Earnings release: Q3 2025

Nov 10, 2025, 5:00 PM EST - 7 months ago

Insight Molecular Diagnostics Earnings release: Q3 2025


Insight Molecular Diagnostics Slides: Investor presentation

Sep 16, 2025, 7:00 AM EDT - 9 months ago

Insight Molecular Diagnostics Slides: Investor presentation


Insight Molecular Diagnostics announces novel registry database

2025-09-08T11:25:06.000Z - 9 months ago

Insight Molecular Diagnostics announces novel registry database


iMDx to Participate in NYC Investment Conferences September 8 - 11

Aug 26, 2025, 4:05 PM EDT - 10 months ago

iMDx to Participate in NYC Investment Conferences September 8 - 11


Insight Molecular Diagnostics Transcript: KOL event

Aug 15, 2025, 4:00 PM EDT - 10 months ago

Insight Molecular Diagnostics Transcript: KOL event


Insight Molecular Diagnostics Slides: KOL event

Aug 15, 2025, 4:00 PM EDT - 10 months ago

Insight Molecular Diagnostics Slides: KOL event


Insight Molecular Diagnostics Earnings Call Transcript: Q2 2025

Aug 11, 2025, 5:00 PM EDT - 10 months ago

Insight Molecular Diagnostics Earnings Call Transcript: Q2 2025


Insight Molecular Diagnostics Shareholder letter: Q2 2025

Aug 11, 2025, 5:00 PM EDT - 10 months ago

Insight Molecular Diagnostics Shareholder letter: Q2 2025


Insight Molecular Diagnostics Quarterly report: Q2 2025

Aug 11, 2025, 5:00 PM EDT - 10 months ago

Insight Molecular Diagnostics Quarterly report: Q2 2025


Insight Molecular Diagnostics Earnings release: Q2 2025

Aug 11, 2025, 5:00 PM EDT - 10 months ago

Insight Molecular Diagnostics Earnings release: Q2 2025


Insight Molecular Diagnostics Slides: Q2 2025

Aug 11, 2025, 5:00 PM EDT - 10 months ago

Insight Molecular Diagnostics Slides: Q2 2025


Insight Molecular Diagnostics Proxy statement: Proxy Filing

May 14, 2025, 8:00 AM EDT - 1 year ago

Insight Molecular Diagnostics Proxy statement: Proxy Filing


Insight Molecular Diagnostics Proxy statement: Proxy Filing

May 14, 2025, 8:00 AM EDT - 1 year ago

Insight Molecular Diagnostics Proxy statement: Proxy Filing


Insight Molecular Diagnostics Shareholder letter: Q1 2025

May 12, 2025, 5:00 PM EDT - 1 year ago

Insight Molecular Diagnostics Shareholder letter: Q1 2025


Insight Molecular Diagnostics Earnings release: Q1 2025

May 12, 2025, 5:00 PM EDT - 1 year ago

Insight Molecular Diagnostics Earnings release: Q1 2025


Insight Molecular Diagnostics Quarterly report: Q1 2025

May 12, 2025, 5:00 PM EDT - 1 year ago

Insight Molecular Diagnostics Quarterly report: Q1 2025


Oncocyte Reports Q1 2025 Results and Business Progress

May 12, 2025, 4:05 PM EDT - 1 year ago

Oncocyte Reports Q1 2025 Results and Business Progress


Oncocyte Provides Positive Update on Clinical Trial Progress

Apr 30, 2025, 8:30 AM EDT - 1 year ago

Oncocyte Provides Positive Update on Clinical Trial Progress


Insight Molecular Diagnostics Shareholder letter: Q4 2024

Mar 24, 2025, 5:00 PM EDT - 1 year ago

Insight Molecular Diagnostics Shareholder letter: Q4 2024


Insight Molecular Diagnostics Annual report: Q4 2024

Mar 24, 2025, 5:00 PM EDT - 1 year ago

Insight Molecular Diagnostics Annual report: Q4 2024


Insight Molecular Diagnostics Earnings release: Q4 2024

Mar 24, 2025, 5:00 PM EDT - 1 year ago

Insight Molecular Diagnostics Earnings release: Q4 2024


Insight Molecular Diagnostics Slides: Q4 2024

Mar 24, 2025, 5:00 PM EDT - 1 year ago

Insight Molecular Diagnostics Slides: Q4 2024


Oncocyte Expands Market Opportunity for VitaGraft™ Kidney

Jan 6, 2025, 4:05 PM EST - 1 year ago

Oncocyte Expands Market Opportunity for VitaGraft™ Kidney


Insight Molecular Diagnostics Earnings release: Q3 2024

Nov 12, 2024, 5:00 PM EST - 1 year ago

Insight Molecular Diagnostics Earnings release: Q3 2024


Insight Molecular Diagnostics Shareholder letter: Q3 2024

Nov 12, 2024, 5:00 PM EST - 1 year ago

Insight Molecular Diagnostics Shareholder letter: Q3 2024


Insight Molecular Diagnostics Quarterly report: Q3 2024

Nov 12, 2024, 5:00 PM EST - 1 year ago

Insight Molecular Diagnostics Quarterly report: Q3 2024


Insight Molecular Diagnostics Slides: Q3 2024

Nov 12, 2024, 5:00 PM EST - 1 year ago

Insight Molecular Diagnostics Slides: Q3 2024


Insight Molecular Diagnostics Proxy statement: Proxy Filing

Sep 25, 2024, 8:00 AM EDT - 1 year ago

Insight Molecular Diagnostics Proxy statement: Proxy Filing


Insight Molecular Diagnostics Quarterly report: Q2 2024

Aug 8, 2024, 5:00 PM EDT - 1 year ago

Insight Molecular Diagnostics Quarterly report: Q2 2024


Insight Molecular Diagnostics Earnings release: Q2 2024

Aug 8, 2024, 5:00 PM EDT - 1 year ago

Insight Molecular Diagnostics Earnings release: Q2 2024


Insight Molecular Diagnostics Slides: Investor Presentation

Aug 8, 2024, 8:00 AM EDT - 1 year ago

Insight Molecular Diagnostics Slides: Investor Presentation


Insight Molecular Diagnostics Earnings Call Transcript: Q1 2024

May 15, 2024, 4:30 PM EDT - 2 years ago

Insight Molecular Diagnostics Earnings Call Transcript: Q1 2024


Insight Molecular Diagnostics Quarterly report: Q1 2024

May 15, 2024, 4:30 PM EDT - 2 years ago

Insight Molecular Diagnostics Quarterly report: Q1 2024


Insight Molecular Diagnostics Earnings release: Q1 2024

May 15, 2024, 4:30 PM EDT - 2 years ago

Insight Molecular Diagnostics Earnings release: Q1 2024


Oncocyte Reports First Quarter 2024 Financial Results

May 15, 2024, 4:05 PM EDT - 2 years ago

Oncocyte Reports First Quarter 2024 Financial Results


Insight Molecular Diagnostics Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

Insight Molecular Diagnostics Proxy statement: Proxy Filing


Insight Molecular Diagnostics Earnings Call Transcript: Q4 2023

Apr 12, 2024, 8:00 AM EDT - 2 years ago

Insight Molecular Diagnostics Earnings Call Transcript: Q4 2023


Insight Molecular Diagnostics Annual report: Q4 2023

Apr 12, 2024, 8:00 AM EDT - 2 years ago

Insight Molecular Diagnostics Annual report: Q4 2023


Insight Molecular Diagnostics Earnings release: Q4 2023

Apr 12, 2024, 8:00 AM EDT - 2 years ago

Insight Molecular Diagnostics Earnings release: Q4 2023


Insight Molecular Diagnostics Slides: Investor Presentation

Apr 12, 2024, 8:00 AM EDT - 2 years ago

Insight Molecular Diagnostics Slides: Investor Presentation


Oncocyte Reports Full Year 2023 Financial Results

Apr 12, 2024, 6:00 AM EDT - 2 years ago

Oncocyte Reports Full Year 2023 Financial Results


Insight Molecular Diagnostics Slides: Investor Presentation

Jan 24, 2024, 8:00 AM EST - 2 years ago

Insight Molecular Diagnostics Slides: Investor Presentation


Insight Molecular Diagnostics Quarterly report: Q3 2023

Nov 9, 2023, 8:00 AM EST - 2 years ago

Insight Molecular Diagnostics Quarterly report: Q3 2023


Insight Molecular Diagnostics Earnings release: Q3 2023

Nov 9, 2023, 8:00 AM EST - 2 years ago

Insight Molecular Diagnostics Earnings release: Q3 2023


Insight Molecular Diagnostics Earnings Call Transcript: Q2 2023

Aug 10, 2023, 8:00 AM EDT - 3 years ago

Insight Molecular Diagnostics Earnings Call Transcript: Q2 2023


Insight Molecular Diagnostics Quarterly report: Q2 2023

Aug 10, 2023, 8:00 AM EDT - 3 years ago

Insight Molecular Diagnostics Quarterly report: Q2 2023


Insight Molecular Diagnostics Earnings release: Q2 2023

Aug 10, 2023, 8:00 AM EDT - 3 years ago

Insight Molecular Diagnostics Earnings release: Q2 2023


Oncocyte Announces 1-For-20 Reverse Stock Split

Jul 24, 2023, 1:35 PM EDT - 3 years ago

Oncocyte Announces 1-For-20 Reverse Stock Split


Insight Molecular Diagnostics Proxy statement: Proxy Filing

Jul 21, 2023, 8:00 AM EDT - 3 years ago

Insight Molecular Diagnostics Proxy statement: Proxy Filing


Insight Molecular Diagnostics Proxy statement: Proxy Filing

Jul 10, 2023, 8:00 AM EDT - 3 years ago

Insight Molecular Diagnostics Proxy statement: Proxy Filing


Insight Molecular Diagnostics Proxy statement: Proxy Filing

Jun 30, 2023, 8:00 AM EDT - 3 years ago

Insight Molecular Diagnostics Proxy statement: Proxy Filing


Oncocyte Begins Manufacturing Transplant Blood Test

Jun 27, 2023, 8:30 AM EDT - 3 years ago

Oncocyte Begins Manufacturing Transplant Blood Test


Insight Molecular Diagnostics Proxy statement: Proxy Filing

May 22, 2023, 8:00 AM EDT - 3 years ago

Insight Molecular Diagnostics Proxy statement: Proxy Filing


Insight Molecular Diagnostics Proxy statement: Proxy Filing

May 19, 2023, 8:00 AM EDT - 3 years ago

Insight Molecular Diagnostics Proxy statement: Proxy Filing


Insight Molecular Diagnostics Earnings Call Transcript: Q1 2023

May 11, 2023, 9:00 AM EDT - 3 years ago

Insight Molecular Diagnostics Earnings Call Transcript: Q1 2023


Insight Molecular Diagnostics Quarterly report: Q1 2023

May 11, 2023, 9:00 AM EDT - 3 years ago

Insight Molecular Diagnostics Quarterly report: Q1 2023


Insight Molecular Diagnostics Earnings release: Q1 2023

May 11, 2023, 9:00 AM EDT - 3 years ago

Insight Molecular Diagnostics Earnings release: Q1 2023


Oncocyte Reports First Quarter 2023 Financial Results

May 11, 2023, 8:00 AM EDT - 3 years ago

Oncocyte Reports First Quarter 2023 Financial Results


Oncocyte To Announce First Quarter 2023 Financial Results

Apr 27, 2023, 4:59 PM EDT - 3 years ago

Oncocyte To Announce First Quarter 2023 Financial Results


Oncocyte Presents New Data at AACR

Apr 18, 2023, 8:45 AM EDT - 3 years ago

Oncocyte Presents New Data at AACR


Oncocyte Announces Reduction in Force

Apr 12, 2023, 4:15 PM EDT - 3 years ago

Oncocyte Announces Reduction in Force


JohnPDaly
JohnPDaly Jun. 1 at 1:35 PM
$IMDX bought a little more. Neil B and I own 40% of this company now.
0 · Reply
JohnPDaly
JohnPDaly May. 28 at 4:17 PM
$IMDX bought more.
0 · Reply
SuperGreenToday
SuperGreenToday May. 28 at 2:34 AM
$IMDX Share Price: $6.41 Contract Selected: Dec 18, 2026 $5 Calls Buy Zone: $0.47 – $0.58 Target Zone: $0.80 – $0.97 Potential Upside: 61% ROI Time to Expiration: 204 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
jackedmund99
jackedmund99 May. 27 at 8:01 PM
$IMDX there’s no doubt with the way the Stock has been acting the last couple of months. This Stock is under serious consideration and consolidation and accumulation look at the way you perform today somebody wants to stock in a big way.
0 · Reply
JohnPDaly
JohnPDaly May. 20 at 10:08 PM
$IMDX well, school is out. When school goes back in, we should be approved.
0 · Reply
juliano777
juliano777 May. 20 at 9:39 PM
$IMDX very strong 💪🏽 happy to be in
0 · Reply
jackedmund99
jackedmund99 May. 20 at 7:50 PM
$IMDX Stock is gonna go to 20 or $30. Over the next two years as products come out there’s a huge market there and people aren’t even paying attention.
1 · Reply
quiet_investor_
quiet_investor_ May. 19 at 4:43 PM
$IMDX holding since the $4's bought more at lunch today.
0 · Reply
Logic102
Logic102 May. 18 at 2:24 PM
$IMDX An Oasis in a Sea of Red with the sector being beaten down with the FDA turmoil.
0 · Reply
WarrenPsnik
WarrenPsnik May. 14 at 6:54 PM
$IMDX Still holding, but didn’t get to add anymore …
1 · Reply
JohnPDaly
JohnPDaly May. 14 at 4:48 PM
$IMDX Rich Uncle Neal having a day.
1 · Reply
Logic102
Logic102 May. 14 at 4:42 PM
$IMDX Wow, the ST Earnings summary looks slanted to Bearish, yet the Market doesn't think so.
0 · Reply
Bogwood
Bogwood May. 14 at 4:14 PM
$IMDX They can't get enough of it!
0 · Reply
Bogwood
Bogwood May. 14 at 3:34 AM
$IMDX Not a single IQ sale this past Q 🤢🤮 At least the letter highlights that 2Q will be great, but wow we need to hope the FDA can keep the August date
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 13 at 9:26 PM
$IMDX Q1 '26 Earnings Results & Recap Insight Molecular Diagnostics Inc. anticipates continued operating losses and negative operating cash flows for the foreseeable future, though management believes it has sufficient cash to meet projected operating requirements for at least the next twelve months.
0 · Reply
jackedmund99
jackedmund99 May. 5 at 5:52 PM
$IMDX Refinitiv/Verus is a high-performing, quantitative independent research firm- this clown firm put a sale on Stock yesterday while it was going up a dollar it’s a quantitative research company. They have no foresight no intuition. They look at everything from quantitative analytical viewpoint obviously not doing a deep dive not talking to anybody just purely odd numbers so in the grand scheme of things they’re irrelevant.
0 · Reply
jackedmund99
jackedmund99 May. 5 at 5:48 PM
$IMDX huge volume yesterday whoever’s buying is letting it drift down and the little guys get out. Let let it fall. I believe they’ll be back closer to 4 1/4.
0 · Reply
WarrenPsnik
WarrenPsnik May. 5 at 2:23 PM
$IMDX Starter at $4.80 … (25%), long. Will look to add more on weakness (if there is) eyeing closer to $4.20 average
0 · Reply
StockScanners
StockScanners May. 5 at 5:25 AM
$IMDX keep watch if this holds above 4.98
0 · Reply
RUNNINWILD
RUNNINWILD May. 5 at 4:26 AM
$IMDX https://stocks.apple.com/AVpkzXASkQLalf1EDJGT4bg
0 · Reply
RUNNINWILD
RUNNINWILD May. 5 at 4:20 AM
$IMDX steady now, lads
0 · Reply
topstockalerts
topstockalerts May. 4 at 8:31 PM
$IMDX this is quietly putting in work while everything else chops
0 · Reply